Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-09-04
1999-08-31
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514215, 540580, 546113, 546122, 546123, A61K 31435, C07D47104
Patent
active
059454318
ABSTRACT:
The present invention relates to heterocyclic compounds having antiviral activity. In particular, compounds of formula (I): wherein B, W, X, Y, R.sub.1, R.sub.2, R.sub.3, R.sub.4 and n are as defined herein, are useful in the therapy and prophylaxis of cytomegalovirus (CMV) infection in mammals.
REFERENCES:
patent: 4786644 (1988-11-01), Glamkowski et al.
patent: 4959363 (1990-09-01), Wentland
Peakdale's Fine Chemicals, 1995 Collection, pp. 1-38.
Peakdale's Fine Chemicals, 1994 Collection, pp. 1-41.
Peakdale's Fine Chemicals: Chemical Family 122 (PFC's 798-803); Chemical Family 123 (PFC's 804-813); and Chemical Family 124 (PFC's 814-819), respectively (1996).
Chan Laval C.
Falardeau Guy
Jin Haolun
Lavallee Jean-Francois
Mansour Tarek S.
Biochem Therapeutics Incorporated
Dentz Bernard
LandOfFree
Cytomegalovirus inhibiting compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cytomegalovirus inhibiting compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytomegalovirus inhibiting compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2426592